{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:08:36Z","timestamp":1791893316476,"version":"4.3.4"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PNRR-POC-2023\\u201312377609"],"award-info":[{"award-number":["PNRR-POC-2023\\u201312377609"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118396","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T14:12:35Z","timestamp":1754057555000},"page":"118396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Carbonic anhydrases inhibition in the management of cardiovascular and cardiometabolic disorders"],"prefix":"10.1016","volume":"190","author":[{"given":"Alice","family":"Mallia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia G.","family":"Papaianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118396_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","volume":"93","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.biopha.2025.118396_bib5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/14756366.2015.1059333","article-title":"A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization","volume":"31","author":"Ozensoy Guler","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118396_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3002(61)90898-8","article-title":"Purification and properties of carbonic anhydrase from human erythrocytes","volume":"52","author":"Nyman","year":"1961","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1994.1033","article-title":"S-thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues","volume":"308","author":"Lii","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.yexcr.2012.02.011","article-title":"Carbonic anhydrase III regulates peroxisome proliferator-activated receptor-gamma2","volume":"318","author":"Mitterberger","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bmcl.2011.12.134","article-title":"Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors","volume":"22","author":"Truppo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1523\/JNEUROSCI.5176-03.2004","article-title":"Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells","volume":"24","author":"Ruusuvuori","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib13","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1074\/jbc.M308984200","article-title":"Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family","volume":"279","author":"Lehtonen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118396_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2407-5-41","article-title":"Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa","volume":"5","author":"Kummola","year":"2005","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/14756366.2012.727813","article-title":"An update on carbonic anhydrase-related proteins VIII, x and XI","volume":"28","author":"Aspatwar","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-4522(02)00066-0","article-title":"Developmental expression of carbonic anhydrase-related proteins VIII, X, and XI in the human brain","volume":"112","author":"Taniuchi","year":"2002","journal-title":"Neuroscience"},{"issue":"29","key":"10.1016\/j.biopha.2025.118396_bib17","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.2174\/138161210793429823","article-title":"Carbonic anhydrase related protein VIII and its role in neurodegeneration and cancer","volume":"16","author":"Aspatwar","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00428-005-1225-3","article-title":"Overexpression of carbonic anhydrase-related protein XI promotes proliferation and invasion of gastrointestinal stromal tumors","volume":"447","author":"Morimoto","year":"2005","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.89.4.1315","article-title":"Human carbonic anhydrase IV: cDNA cloning, sequence comparison, and expression in COS cell membranes","volume":"89","author":"Okuyama","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/002215549804600709","article-title":"Localization of carbonic anhydrase IV in rat and human heart muscle","volume":"46","author":"Sender","year":"1998","journal-title":"J. Histochem. Cytochem."},{"issue":"28","key":"10.1016\/j.biopha.2025.118396_bib21","doi-asserted-by":"crossref","first-page":"25239","DOI":"10.1074\/jbc.M202562200","article-title":"The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE1 Cl-\/HCO3- exchanger binds carbonic anhydrase IV","volume":"277","author":"Sterling","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/hmg\/ddi023","article-title":"Mutant carbonic anhydrase 4 impairs ph regulation and causes retinal photoreceptor degeneration","volume":"14","author":"Yang","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib25","doi-asserted-by":"crossref","first-page":"C69","DOI":"10.1152\/ajpcell.00431.2011","article-title":"Binding of carbonic anhydrase IX to extracellular loop 4 of the NBCe1 Na+\/HCO3- cotransporter enhances NBCe1-mediated HCO3- influx in the rat heart","volume":"303","author":"Orlowski","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib26","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","author":"Mahon","year":"2015","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib27","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-07-6151","article-title":"Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer","volume":"68","author":"Barnett","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/geno.1999.5938","article-title":"Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression, and mapping to chromosome 1","volume":"61","author":"Fujikawa-Adachi","year":"1999","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.yjmcc.2011.12.008","article-title":"Carbonic anhydrase XIV in the normal and hypertrophic myocardium","volume":"52","author":"Vargas","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2025.118396_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/BJ20051102","article-title":"Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase","volume":"392","author":"Hilvo","year":"2005","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/138161208783877811","article-title":"Recent advances in research on the most novel carbonic anhydrases, CA XIII and XV","volume":"14","author":"Hilvo","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0003-9861(59)90182-1","article-title":"Intracellular localization of carbonic anhydrase in rat liver and kidney tissues","volume":"81","author":"Datta","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1073\/pnas.97.4.1677","article-title":"Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles","volume":"97","author":"Shah","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib34","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/febs.14779","article-title":"Carbonic anhydrases are involved in mitochondrial biogenesis and control the production of lactate by human sertoli cells","volume":"286","author":"Bernardino","year":"2019","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib35","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bmc.2012.06.053","article-title":"Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion","volume":"21","author":"Arechederra","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib36","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1016\/S0021-9258(18)91031-8","article-title":"Purification and characterization of carbonic anhydrase from the saliva of the rat","volume":"259","author":"Feldstein","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118396_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-007-7359-2_2","article-title":"Physiological functions of the alpha class of carbonic anhydrases","volume":"75","author":"Frost","year":"2014","journal-title":"Subcell. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1748-1716.1995.tb09902.x","article-title":"Circadian periodicity in salivary carbonic anhydrase VI concentration","volume":"154","author":"Parkkila","year":"1995","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.biopha.2025.118396_bib39","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fphar.2019.00766","article-title":"Carbonic anhydrase 1-Mediated calcification is associated with atherosclerosis, and methazolamide alleviates its pathogenesis","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2025.118396_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1107\/S2052252520000986","article-title":"Structure and mechanism of copper-carbonic anhydrase II: a nitrite reductase","volume":"7","author":"Andring","year":"2020","journal-title":"IUCrJ"},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib41","doi-asserted-by":"crossref","first-page":"C1522","DOI":"10.1152\/ajpcell.00115.2002","article-title":"The functional and physical relationship between the DRA bicarbonate transporter and carbonic anhydrase II","volume":"283","author":"Sterling","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1113\/JP283579","article-title":"Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease","volume":"601","author":"Aspatwar","year":"2023","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biochi.2010.05.008","article-title":"Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme","volume":"92","author":"Bootorabi","year":"2010","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.urolonc.2021.09.020","article-title":"Carbonic anhydrase 10 functions as a tumor suppressor in renal cell carcinoma and its methylation is a risk factor for survival outcome","volume":"40","author":"Li","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.biopha.2025.118396_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.biopha.2025.118396_bib46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2174\/138161212799504920","article-title":"Acid-extrusion from tissue: the interplay between membrane transporters and ph buffers","volume":"18","author":"Hulikova","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"18","key":"10.1016\/j.biopha.2025.118396_bib47","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1074\/jbc.274.18.12193","article-title":"The molecular basis of substrate channeling","volume":"274","author":"Miles","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00234498","article-title":"Interaction between red cell membrane band 3 and cytosolic carbonic anhydrase","volume":"134","author":"Kifor","year":"1993","journal-title":"J. Membr. Biol."},{"issue":"44","key":"10.1016\/j.biopha.2025.118396_bib49","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1021\/bi0015111","article-title":"Localization of the Cl-\/HCO3- anion exchanger binding site to the amino-terminal region of carbonic anhydrase II","volume":"39","author":"Vince","year":"2000","journal-title":"Biochemistry"},{"issue":"51","key":"10.1016\/j.biopha.2025.118396_bib50","doi-asserted-by":"crossref","first-page":"47886","DOI":"10.1074\/jbc.M105959200","article-title":"A transport metabolon. Functional interaction of carbonic anhydrase II and chloride\/bicarbonate exchangers","volume":"276","author":"Sterling","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.biopha.2025.118396_bib51","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1021\/bi992564p","article-title":"Identification of the carbonic anhydrase II binding site in the Cl(-)\/HCO(3)(-) anion exchanger AE1","volume":"39","author":"Vince","year":"2000","journal-title":"Biochemistry"},{"issue":"45","key":"10.1016\/j.biopha.2025.118396_bib52","doi-asserted-by":"crossref","first-page":"44949","DOI":"10.1074\/jbc.M308660200","article-title":"Deficient HCO3- transport in an AE1 mutant with normal Cl- transport can be rescued by carbonic anhydrase II presented on an adjacent AE1 protomer","volume":"278","author":"Dahl","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib53","doi-asserted-by":"crossref","first-page":"C738","DOI":"10.1152\/ajpcell.00157.2007","article-title":"Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters","volume":"293","author":"Morgan","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib54","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00177.2009","article-title":"Bicarbonate homeostasis in excitable tissues: role of ae3 cl-\/hco3- exchanger and carbonic anhydrase xiv interaction","volume":"297","author":"Casey","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"42","key":"10.1016\/j.biopha.2025.118396_bib55","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1021\/bi0353124","article-title":"Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium\/bicarbonate co-transporter","volume":"42","author":"Alvarez","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118396_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-7359-2_7","article-title":"Carbonic anhydrases and their interplay with acid\/base-coupled membrane transporters","volume":"75","author":"Becker","year":"2014","journal-title":"Subcell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002329900339","article-title":"Cytoplasmic ph responses to carbonic anhydrase inhibitors in cultured rabbit nonpigmented ciliary epithelium","volume":"162","author":"Wu","year":"1998","journal-title":"J. Membr. Biol."},{"issue":"39","key":"10.1016\/j.biopha.2025.118396_bib58","doi-asserted-by":"crossref","first-page":"36085","DOI":"10.1074\/jbc.M111952200","article-title":"Carbonic anhydrase II binds to and enhances activity of the Na+\/H+ exchanger","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib59","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"15","key":"10.1016\/j.biopha.2025.118396_bib61","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.bmcl.2007.05.045","article-title":"Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies","volume":"17","author":"Alterio","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8-9","key":"10.1016\/j.biopha.2025.118396_bib62","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1042\/bj0341163","article-title":"Carbonic anhydrase. Purification and nature of the enzyme","volume":"34","author":"Keilin","year":"1940","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.biopha.2025.118396_bib63","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib64","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1016\/j.bmcl.2011.04.046","article-title":"Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action","volume":"21","author":"Mincione","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib65","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"issue":"15","key":"10.1016\/j.biopha.2025.118396_bib66","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/jm1003667","article-title":"Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule","volume":"53","author":"Carta","year":"2010","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib67","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.bmc.2012.05.019","article-title":"Mono-\/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV","volume":"21","author":"Carta","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib68","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","article-title":"Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV)","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"43","key":"10.1016\/j.biopha.2025.118396_bib69","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1039\/c2cc32013d","article-title":"Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","volume":"48","author":"Martin","year":"2012","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib70","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/jm1013242","article-title":"Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases","volume":"54","author":"Davis","year":"2011","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.biopha.2025.118396_bib72","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1016\/j.bmc.2015.10.018","article-title":"New natural product carbonic anhydrase inhibitors incorporating phenol moieties","volume":"23","author":"Karioti","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib73","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","article-title":"Carbonic anhydrase inhibitors: in vitro inhibition of alpha isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids","volume":"28","author":"Ekinci","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib76","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"53","author":"Temperini","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C4CC07320G","article-title":"Out of the active site binding pocket for carbonic anhydrase inhibitors","volume":"51","author":"D'Ambrosio","year":"2015","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/chem.201503748","article-title":"A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases","volume":"22","author":"Langella","year":"2016","journal-title":"Chemistry"},{"issue":"Pt 2","key":"10.1016\/j.biopha.2025.118396_bib79","article-title":"Drug repurposing: identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II","volume":"305","author":"Rasheed","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118396_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108224","article-title":"Carbonic anhydrase inhibitors: structural insights and therapeutic potential","volume":"156","author":"Singh","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib81","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/jm0108202","article-title":"Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties","volume":"45","author":"Scozzafava","year":"2002","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200554","article-title":"Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif","volume":"356","author":"Demir","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.biopha.2025.118396_bib84","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"\u00d6zcan G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14656566.2025.2474574","article-title":"Polypharmacology of carbonic anhydrase inhibitors and activators","volume":"26","author":"Bonardi","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib86","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.124.001125","article-title":"Multi- and polypharmacology of carbonic anhydrase inhibitors","volume":"77","author":"Supuran","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib87","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2025.118396_bib88","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1139\/y2012-142","article-title":"Carbonic anhydrase II promotes cardiomyocyte hypertrophy","volume":"90","author":"Brown","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib89","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00424-021-02592-5","article-title":"Carbonic anhydrase IX and hypoxia-inducible factor 1 attenuate cardiac dysfunction after myocardial infarction","volume":"473","author":"Nolly","year":"2021","journal-title":"Pflug. Arch."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib90","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2015.05.012","article-title":"The role of carbonic anhydrase in the pathogenesis of vascular calcification in humans","volume":"241","author":"Adeva-Andany","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchf.2024.09.017","article-title":"Diuretic potentiation strategies in acute heart failure","volume":"13","author":"Siddiqi","year":"2025","journal-title":"JACC Heart Fail."},{"issue":"48","key":"10.1016\/j.biopha.2025.118396_bib92","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.biopha.2025.118396_bib93","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1113\/expphysiol.2014.081562","article-title":"Sildenafil, nifedipine and acetazolamide do not allow for blood flow through intrapulmonary arteriovenous anastomoses during exercise while breathing 100% oxygen","volume":"99","author":"Elliott","year":"2014","journal-title":"Exp. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib94","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.0000000000000122","article-title":"Thiazides attenuate insulin secretion through inhibition of mitochondrial carbonic anhydrase 5b in beta -Islet cells in mice","volume":"34","author":"Kucharczyk","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib95","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib96","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0021-9681(55)90195-8","article-title":"A comparative study of neohydrin and diamox when used alone and in combination for the treatment of severe congestive heart failure","volume":"2","author":"Moyer","year":"1955","journal-title":"J. Chronic Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib97","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib98","doi-asserted-by":"crossref","first-page":"2291336","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib99","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib100","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/CIRCULATIONAHA.106.626929","article-title":"Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy","volume":"115","author":"Cingolani","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib101","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.RES.0000014966.97486.C0","article-title":"Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice","volume":"90","author":"Engelhardt","year":"2002","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib102","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.RES.77.6.1192","article-title":"Phi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Na(+)-H+ exchanger","volume":"77","author":"Perez","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118396_bib103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2261-13-2","article-title":"Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart","volume":"13","author":"Alvarez","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2025.118396_bib104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1113\/jphysiol.2006.123638","article-title":"Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy","volume":"579","author":"Alvarez","year":"2007","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib105","first-page":"S134","article-title":"pH-Regulated Na(+) influx into the mammalian ventricular myocyte: the relative role of Na(+)-H(+) exchange and Na(+)-HCO Co-transport","volume":"17","author":"Vaughan-Jones","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib106","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1113\/jphysiol.2013.265439","article-title":"Facilitation by intracellular carbonic anhydrase of na+ -HCO3- co-transport but not na+ \/ H+ exchange activity in the mammalian ventricular myocyte","volume":"592","author":"Villafuerte","year":"2014","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118396_bib107","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","article-title":"Acetazolamide as Add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study","volume":"37","author":"Imiela","year":"2017","journal-title":"Clin. Drug Investig.."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12465","article-title":"Use of acetazolamide in the treatment of patients with refractory congestive heart failure","volume":"36","author":"Nunez","year":"2018","journal-title":"Cardiovasc. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib109","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/ejhf.2968","article-title":"Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: key insights into ADVOR and EMPULSE","volume":"25","author":"Packer","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib111","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ejhf.1307","article-title":"Rationale and design of the ADVOR (Acetazolamide in decompensated heart failure with volume overload) trial","volume":"20","author":"Mullens","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib112","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/ejhf.2587","article-title":"Acetazolamide in decompensated heart failure with volume overload trial (ADVOR): baseline characteristics","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"13","key":"10.1016\/j.biopha.2025.118396_bib113","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118396_bib114","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3762\/bjnano.5.72","article-title":"Biocalcite, a multifunctional inorganic polymer: building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone","volume":"5","author":"Wang","year":"2014","journal-title":"Beilstein J. Nanotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib115","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.biortech.2009.10.061","article-title":"Enhanced algal CO(2) sequestration through calcite deposition by chlorella sp. and spirulina platensis in a mini-raceway pond","volume":"101","author":"Ramanan","year":"2010","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.biopha.2025.118396_bib116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.acc.2020.02.004","article-title":"Biomarkers of vascular calcification in serum","volume":"98","author":"Roumeliotis","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib117","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/ATVBAHA.113.302642","article-title":"Has our understanding of calcification in human coronary atherosclerosis progressed?","volume":"34","author":"Otsuka","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib118","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0037-1613115","article-title":"The vitamin K-dependent carboxylase","volume":"87","author":"Presnell","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib119","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2478\/v10039-012-0056-0","article-title":"Microarray analysis reveals overexpression of IBSP in human carotid plaques","volume":"57","author":"Ayari","year":"2012","journal-title":"Adv. Med.Sci."},{"key":"10.1016\/j.biopha.2025.118396_bib120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fendo.2018.00207","article-title":"Therapeutic interference with vascular Calcification-Lessons from Klotho-Hypomorphic mice and beyond","volume":"9","author":"Lang","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib121","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/07853890.2010.486408","article-title":"Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere vascular study","volume":"42","author":"Oksala","year":"2010","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib122","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/14756366.2020.1781844","article-title":"The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes","volume":"35","author":"Argan","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0366-6999.149226","article-title":"Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients","volume":"128","author":"Ye","year":"2015","journal-title":"Chin. Med. J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib124","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11883-002-0074-7","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis","volume":"4","author":"Lonn","year":"2002","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mayocp.2019.05.001","article-title":"Acute myocardial infarction in young individuals","volume":"95","author":"Gulati","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib126","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00782.2005","article-title":"Physiology and pathophysiology of Na+\/H+ exchange and na+ -K+ -2Cl- cotransport in the heart, brain, and blood","volume":"291","author":"Pedersen","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib127","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/ars.2010.3312","article-title":"Contribution of delayed intracellular ph recovery to ischemic postconditioning protection","volume":"14","author":"Inserte","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1152\/physrev.00024.2007","article-title":"Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury","volume":"88","author":"Murphy","year":"2008","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1008990530176","article-title":"Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition","volume":"8","author":"Karmazyn","year":"1999","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin","volume":"290","author":"Svastova","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1464-410X.2008.07642.x","article-title":"Molecular mechanisms of carbonic anhydrase IX-mediated ph regulation under hypoxia","volume":"101","author":"Pastorekova","year":"2008","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib132","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00424-007-0400-6","article-title":"Induction of carbonic anhydrase IX by hypoxia and chemical disruption of oxygen sensing in rat fibroblasts and cardiomyocytes","volume":"456","author":"Holotnakova","year":"2008","journal-title":"Pflug. Arch."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib133","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1152\/japplphysiol.00957.2017","article-title":"Benzolamide perpetuates acidic conditions during reperfusion and reduces myocardial ischemia-reperfusion injury","volume":"125","author":"Ciocci Pardo","year":"2018","journal-title":"J. Appl. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib134","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.carpath.2016.08.003","article-title":"Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats","volume":"25","author":"Vargas","year":"2016","journal-title":"Cardiovasc. Pathol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118396_bib135","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15093","article-title":"Myocardial and mitochondrial effects of the anhydrase carbonic inhibitor ethoxzolamide in ischemia-reperfusion","volume":"9","author":"Ciocci Pardo","year":"2021","journal-title":"Physiol. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2025.118396_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/biology11081189","article-title":"Correlation between carbonic anhydrase isozymes and the evolution of myocardial infarction in diabetic patients","volume":"11","author":"Magheru","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2025.118396_bib137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2019.09.005","article-title":"Carbonic anhydrase II\/sodium-proton exchanger 1 metabolon complex in cardiomyopathy of Ob(-\/-) type 2 diabetic mice","volume":"136","author":"Jaquenod De Giusti","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2025.118396_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123506","article-title":"The canonical Wnt\/beta-catenin signaling pathway upregulates carbonic anhydrase 2 via transcription factor 7-like 2 to promote cardiomyopathy in type 2 diabetic mice","volume":"368","author":"Li","year":"2025","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib139","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000434","article-title":"Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy","volume":"3","author":"Torella","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"5513","key":"10.1016\/j.biopha.2025.118396_bib140","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1126\/science.1056374","article-title":"Influence of carbonic anhydrase activity in terrestrial vegetation on the 18O content of atmospheric CO2","volume":"291","author":"Gillon","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118396_bib141","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1038\/srep08137","article-title":"Oxygen-18 isotope of breath CO(2) linking to erythrocytes carbonic anhydrase activity: a biomarker for pre-diabetes and type 2 diabetes","volume":"5","author":"Ghosh","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib142","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00125-023-05943-2","article-title":"Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4\/F4\/FF4 study","volume":"66","author":"Luo","year":"2023","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib143","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00316069","article-title":"Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O.","volume":"97","author":"Ramirez-Zacarias","year":"1992","journal-title":"Histochemistry"},{"issue":"4 Pt 1","key":"10.1016\/j.biopha.2025.118396_bib144","first-page":"E621","article-title":"Carbonic anhydrase III in obese zucker rats","volume":"264","author":"Lynch","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030542","article-title":"Prenylcysteine oxidase 1 is a key regulator of adipogenesis","volume":"12","author":"Banfi","year":"2023","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib146","article-title":"Gene expression profile change and associated physiological and pathological effects in mouse liver induced by fasting and refeeding","volume":"6","author":"Zhang","year":"2011","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib147","first-page":"E79","article-title":"Combined proteomic analysis of liver tissue and serum in chronically alcohol-fed rats","volume":"37","author":"Yamada","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2025.118396_bib148","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jnutbio.2016.12.005","article-title":"Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according to quantitative proteomics","volume":"41","author":"Mendez","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176502","article-title":"Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice","volume":"12","author":"Renner","year":"2017","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/2211-5463.13376","article-title":"Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation","volume":"12","author":"Yamamoto","year":"2022","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib151","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbalip.2016.08.011","article-title":"Mitochondrial fatty acid synthesis, fatty acids and mitochondrial physiology","volume":"1862","author":"Kastaniotis","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.biopha.2025.118396_bib152","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajhg.2014.01.006","article-title":"Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood","volume":"94","author":"van Karnebeek","year":"2014","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib153","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2174\/1389203718666170810145436","article-title":"Understanding the role and mechanism of carbonic anhydrase v in obesity and its therapeutic implications","volume":"19","author":"Queen","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"issue":"209","key":"10.1016\/j.biopha.2025.118396_bib154","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-642-24716-3_20","article-title":"Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide","author":"Antel","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib155","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/oby.2000.84","article-title":"Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) zucker rats","volume":"8","author":"Picard","year":"2000","journal-title":"Obes. Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118396_bib156","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.2007.136929","article-title":"Topiramate, nutrition and weight change: a prospective study","volume":"79","author":"Klein","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9774","key":"10.1016\/j.biopha.2025.118396_bib157","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2025.118396_bib158","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"14","key":"10.1016\/j.biopha.2025.118396_bib159","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/jama.289.14.1820","article-title":"Zonisamide for weight loss in obese adults: a randomized controlled trial","volume":"289","author":"Gadde","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib160","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","article-title":"Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies","volume":"15","author":"De Simone","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118396_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.588016","article-title":"Case report: off label utilization of topiramate and metformin in patients with BMI >\/=50 kg\/m(2) prior to bariatric surgery","volume":"12","author":"Sari","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118396_bib162","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib163","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1080\/14756366.2022.2121393","article-title":"Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities","volume":"37","author":"Supuran","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib164","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chembiol.2012.01.002","article-title":"Mass spectrometry-based proteomics in preclinical drug discovery","volume":"19","author":"Schirle","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118396_bib165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jprot.2012.10.003","article-title":"Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors","volume":"78","author":"Brioschi","year":"2013","journal-title":"J. Proteom."},{"issue":"4","key":"10.1016\/j.biopha.2025.118396_bib166","article-title":"Chemical proteomics approaches for protein post-translational modification studies","volume":"1872","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Proteins Prot."},{"key":"10.1016\/j.biopha.2025.118396_bib167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.pmbts.2024.02.001","article-title":"Drug repurposing: a multi targetted approach to treat cardiac disease from existing classical drugs to modern drug discovery","volume":"207","author":"Tripathi","year":"2024","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib168","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cbpa.2012.12.022","article-title":"Target deconvolution techniques in modern phenotypic profiling","volume":"17","author":"Lee","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118396_bib169","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.drudis.2017.03.001","article-title":"Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins","volume":"22","author":"Banfi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118396_bib170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.apcsb.2021.03.005","article-title":"Posttranslational modifications in systems biology","volume":"127","author":"Aggarwal","year":"2021","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118396_bib171","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acs.accounts.1c00065","article-title":"Reimagining druggability using chemoproteomic platforms","volume":"54","author":"Spradlin","year":"2021","journal-title":"Acc. Chem. Res"},{"issue":"15","key":"10.1016\/j.biopha.2025.118396_bib172","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1039\/D1CS00231G","article-title":"Chemoproteomic methods for covalent drug discovery","volume":"50","author":"Chan","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2025.118396_bib173","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14789450.2021.2017776","article-title":"Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle","volume":"18","author":"Dowling","year":"2021","journal-title":"Expert Rev. Proteom."},{"issue":"9","key":"10.1016\/j.biopha.2025.118396_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202000140","article-title":"Advances in quantitative high-throughput phosphoproteomics with sample multiplexing","volume":"21","author":"Paulo","year":"2021","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00360-015-0942-4","article-title":"Phosphorylation increases the catalytic activity of rainbow trout gill cytosolic carbonic anhydrase","volume":"186","author":"Carrie","year":"2016","journal-title":"J. Comp. Physiol. B"},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib176","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1080\/14756366.2020.1781846","article-title":"Human carbonic anhydrases and post-translational modifications: a hidden world possibly affecting protein properties and functions","volume":"35","author":"Di Fiore","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118396_bib177","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cbpa.2012.12.023","article-title":"Comprehending dynamic protein methylation with mass spectrometry","volume":"17","author":"Afjehi-Sadat","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"7-8","key":"10.1016\/j.biopha.2025.118396_bib178","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/prca.201400181","article-title":"Proteomics in pharmaceutical research and development","volume":"9","author":"Cutler","year":"2015","journal-title":"Proteom. Clin. Appl."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:56:38Z","timestamp":1762311398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":178,"alternative-id":["S0753332225005906"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118396","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrases inhibition in the management of cardiovascular and cardiometabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118396"}}